Viatris (VTRS) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.75 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 1.47%. A quarter ago, it was expected that this generic drugmaker would post earnings of $0.68 per share when it actually produced earnings of $0.67, delivering a surprise of -1.47%. Over the last four quarters, the compan ...

PITTSBURGH, Aug. 6, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on August 5, 2024, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The dividend is payable on September 13, 2024, to shareholders of record as of the close of business on August 23, 2024. About Viatris Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generic ...

PITTSBURGH, July 2, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that the Antitrust Division of the U.S. Department of Justice ("DOJ") has advised that it no longer considers Mylan, and its former President, Rajiv Malik, a subject of its antitrust investigation in the generic drug industry. The Civil Division of the DOJ has also informed the Company that it does not expect to take any further actions in connection with a civil investigative demand related to the pricing and sales of gene ...

PITTSBURGH, June 25, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to the inaugural edition of TIME's World's Most Sustainable Companies 2024. This recognition is presented by TIME and Statista Inc., the world-leading statistics portal and industry ranking provider. The World's Most Sustainable Companies 2024 list recognizes leading companies in corporate social responsibility from over 30 countries. Companies were evaluated in more tha ...

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acu ...

Viatris Inc. (NASDAQ:VTRS) Jefferies 2024 Global Healthcare Conference Call June 6, 2024 8:00 AM ET Company Participants Scott Smith - Chief Executive Officer Doretta Mistras - Chief Financial Officer Philippe Martin - Chief R&D Officer Conference Call Participants Glen Santangelo All right. Well, good morning, everybody. Thank you for joining this early. We're excited to get Day 3 going to the Jefferies Healthcare Conference. For our next presentation, we're excited to have Viatris with us here today. For ...

About Viatris Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the en ...

PITTSBURGH, June 3, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that as part of its ongoing Board refreshment efforts, Rogerio Vivaldi Coelho, M.D., has been appointed as the newest member of its Board of Directors. Dr. Vivaldi will serve as a member of the recently reestablished Science and Technology Committee of the Board of Directors. Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of DirectorsViatris Appoints Rogerio Vivaldi Coelho, M.D., to Bo ...

Company Participation in Industry Conference - Viatris Inc will participate in the Jeffries Global Healthcare Conference on June 6, 2024, in New York [1] - CEO Scott A Smith and company executives will engage in a fireside chat at 8 am ET during the conference [1] - A live webcast of the event will be available at investor viatris com, with an archived version accessible for a limited time post-event [2] Company Overview and Market Position - Viatris Inc is a global healthcare company uniquely positioned to bridge the gap between generics and brands [3] - The company supplies high-quality medicines to approximately 1 billion patients annually worldwide [3] - Viatris operates with a mission to empower people globally to live healthier at every stage of life, addressing healthcare needs from birth to end-of-life care [3] - The company boasts an extensive and diverse portfolio of medicines, a unique global supply chain, and scientific expertise to tackle enduring health challenges [3] - Viatris is headquartered in the US, with global centers in Pittsburgh, Shanghai, and Hyderabad, India [3]

DNY59 In our last coverage of Viatris Inc. (NASDAQ?VTRS) we pointed out that the company was the epitome of a value trap. It looked cheap and appealed to the "low "P/E" crowd. But the melting ice cube prevented any returns for all but those that bought the extreme dips and sold the minor rips. The chart below shows the performance of VTRS and its predecessor, Mylan Labs. Mylan Labs was combined with the generic unit of Pfizer Inc. (PFE) and started trading as VTRS in November 2020. VAI Viatris Inc (VTRS) Pr ...